Table 2.
Antagonist | Species | Tissue system | Agonist | pA2 | Reference |
---|---|---|---|---|---|
DP1 receptor | |||||
AH-6809 | Human | Neutrophil/superoxide release | BW-245C | 6.55 | Wheeldon and Vardey (1993) |
BW-245C | 6.59 | Lydford et al. (1996a) | |||
Platelet/aggregation | PGD2 | 6.27a | Keery and Lumley (1988) | ||
Cow | Embryonic tracheal fibroblast/cAMP | PGD2 | 6.36 | Ito et al. (1990) | |
Rabbit | Saphenous vein | BW-245C | 5.93 | Lydford et al. (1996c) | |
BW-A868C | Human | Neutrophil/superoxide release | BW-245C | 9.46 | Lydford et al. (1996a) |
Platelet/aggregation | BW-245C | 9.26 | Giles et al. (1989) | ||
Pulmonary vein | PGD2 | 7.84 | Walch et al. (1999) | ||
Uterus (non-pregnant) | BW-245C | 8.3 | Senior et al. (1992) | ||
Uterus (pregnant) | BW-245C | 8.6 | Senior et al. (1993) | ||
Cow | Embryonic tracheal fibroblast/cAMP | BW-245C | 8.0 | Crider et al. (1999) | |
Dog | Nasal vein | BW-245C | 7.3 | Liu et al. (1996a) | |
Tracheal epithelium/Cl- secretion | BW-245C | 8.16 | Liu et al. (1996b) | ||
Rabbit | Jugular vein | BW-245C | 8.73 | Giles et al. (1989) | |
Saphenous vein | BW-245C | 8.50 | Lydford et al. (1996c) | ||
MK-0524 (Laropiprant) | Human | rc-DP1/HEK-293E/binding | [3H]-PGD2 | 10.5b | Sturino et al. (2007) |
Platelet/cAMP | PGD2 | 10.05c | Sturino et al. (2007) | ||
ONO-AE3-237 | Human | rc-DP1/CHO/binding | [3H]-PGD2 | 7.74 | Torisu et al. (2004c) |
S-5751 | Human | Platelet/cAMP | PGD2 | 9.02b,c | Arimura et al. (2001) |
Guinea pig | Platelet/cAMP | PGD2 | 7.50b,c | Arimura et al. (2001) | |
ZK-138357 | Human | Neutrophil/superoxide release | BW-245C | 7.25 | Lydford et al. (1996a) |
Rabbit | Saphenous vein | BW-245C | 5.05 | Lydford et al. (1996a) | |
Rat | Peritoneal mast cell | BW-245C | ∼6.0 | Chan et al. (2000) | |
Compound 1 | Human | Platelet/binding | [3H]-PGD2 | 6.22 | Mitsumori et al. (2003a) |
Compound 2 | Human | Platelet/binding | [3H]-PGD2 | 7.62 | Mitsumori et al. (2003a) |
Compound 3 | Human | rc-DP1/HEK-293-Gα15/Ca2+ | BW-245C | [∼7.4] | Krauss et al. (2005) |
Compound 4 | Human | rc-DP1/CHO/binding | [3H]-PGD2 | 8.27 | Torisu et al. (2004c) |
Compound 5 | Human | rc-DP1/HEK-293/binding | [3H]-PGD2 | 9.0 | Beaulieu et al. (2008) |
DP2 receptor | |||||
BAY-u3405 (Ramatroban) | Human | rc-DP2/CHO/GTPγS binding | PGD2 | 7.44 | Mathiesen et al. (2006) |
Eosinophil/shape change | PGD2 | ∼8.0a | Mathiesen et al. (2006) | ||
K-117 | Human | rc-DP2/HEK-293/binding | [3H]-PGD2 | 8.26 | Mimura et al. (2005) |
K-604 | Human | rc-DP2/HEK-293/binding | [3H]-PGD2 | 7.96 | Mimura et al. (2005) |
TM-30089d (CAY-10471) | Human | rc-DP2/HEK-293/binding | [3H]-PGD2 | 8.74 | Mathiesen et al. (2006) |
9.22 | Ulven and Kostenis (2005) | ||||
Compound 6 | Human | rc-DP2/pre-B L1.2/Ca2+ | PGD2 | [6.8] | Bauer et al. (2002) |
Compound 7 | Human | rc-DP2/HEK-293/binding | [3H]-PGD2 | 8.64c | Birkinshaw et al. (2006) |
Compound 8 | Human | rc-DP2/HEK-293/binding | [3H]-PGD2 | [9.40]c | Bonnert and Rasul (2004) |
Compound 9 | Human | rc-DP2/CHO/binding | [3H]-PGD2 | 7.17 | Armer et al. (2005) |
Eosinophil/shape change | PGD2 | 7.13c | Armer et al. (2005) | ||
Th2-lymphocyte/chemotaxis | PGD2 | 7.17c | Armer et al. (2005) | ||
Compound 10 | Human | rc-DP2/CHO/Ca2+ | PGD2 | [8.53] | Fretz et al. (2005) |
Compound 11 | Human | rc-DP2/HEK-293/binding | [3H]-PGD2 | [9.0] | Bonnert et al. (2005c) |
EP1 receptor | |||||
AH-6809 | Human | rc-EP1/HEK-293E/reporter gene | Iloprost | ∼6.4 | Durocher et al. (2000) |
Pulmonary vein | Sulprostone | 5.52 | Walch et al. (2001) | ||
Guinea pig | Ileum | PGE2 | 6.8 | Coleman et al. (1987) | |
Ileum | PGE2 | 7.39 | Eglen and Whiting (1988) | ||
Ileum | PGE1 | 7.42 | Eglen and Whiting (1988) | ||
Ileum | 16,16-DM PGE2 | 7.59 | Eglen and Whiting (1988) | ||
Trachea | 16,16-DM PGE2 | 7.48 | Eglen and Whiting (1988) | ||
Trachea | 17-Phenyl PGE2 | 7.35 | Lawrence et al. (1992) | ||
GW-848687 | Human | rc-EP1/not given/reporter gene | PGE2 | 9.1 | Giblin et al. (2007) |
MF-266-1 | Human | rc-EP1/HEK-293/Ca2+ | PGE2 | 7.8 | Clark et al. (2008) |
ONO-8711 | Mouse | rc-EP1/CHO/binding | [3H]-PGE2 | 8.77 | Watanabe et al. (1999) |
Human | rc-EP1/CHO/binding | [3H]-PGE2 | 9.22 | Watanabe et al. (1999) | |
ONO-8713 | Mouse | rc-EP1/not given/binding | [3H]-PGE2 | 9.5 | Narumiya and Fitzgerald (2001) |
SC-19220 | Guinea pig | Ileum | PGE2 | 5.5 | Sanner (1969) |
Ileum | PGE2 | 5.6 | Bennett and Posner (1971) | ||
Trachea | PGF2α | 6.6 | Farmer et al. (1974) | ||
SC-51089 | Human | rc-EP1/HEK-293E/reporter gene | Iloprost | 6.94 | Durocher et al. (2000) |
Guinea pig | Ileum | PGE2 | 6.5 | Hallinan et al. (1993) | |
Ileum | PGE2 | 6.7 | Sametz et al. (2000) | ||
SC-51322 | Human | rc-EP1/HEK-293E/reporter gene | Iloprost | 8.80 | Durocher et al. (2000) |
Guinea pig | Ileum | PGE2 | 8.1 | Hallinan et al. (1994) | |
Trachea | 17-Phenyl PGE2 | 8.45 | Hung et al. (2006) | ||
Compound 13 | Mouse | rc-EP1/CHO/Ca2+ | PGE2 | 8.25c | Naganawa et al. (2006) |
Compound 14 | Human | rc-EP1/HEK-293E/binding | [3H]-PGE2 | 8.0 | Ruel et al. (1999) |
Compound 15 | Human | rc- EP1/CHO/Ca2+ | PGE2 | 8.2 | Hall et al. (2007b) |
EP2 receptor | |||||
AH-6809 | Human | rc-EP2/COS-7/cAMP | PGE2 | ∼6.5 | Woodward et al. (1995) |
Bronchus | PGE2 | 5.78 | Norel et al. (1999) | ||
Guinea pig | Trachea | PGE2 | 5.7e | KJ Ong and RL Jones (unpublished) | |
EP3 receptor | |||||
DG-041 | Human | rc-EP3/Chem-1/Ca2+ | PGE2 | 8.09c | Singh et al. (2009) |
L-798106 | Guinea pig | Aorta | 17-Phenyl PGE2f | 7.96 | Jones et al. (2008) |
Trachea | Sulprostone | 7.82 | Clarke et al. (2004) | ||
Vas deferens | Sulprostone | 7.48 | Clarke et al. (2004) | ||
L-826266 | Human | rc-EP3/HEK-293E/Ca2+ | PGE2 | 7.97 | R.L. Jones et al. (2008, submitted) |
Erythroleukaemia cell/cAMP | Sulprostone | 8.35 | Clark et al. (2008) | ||
Guinea pig | Aorta | 17-Phenyl PGE2 | 7.58 | R.L. Jones et al. (2008, submitted) | |
ONO-AE3-240 | Mouse | rc-EP3/not given/Ca2+ | PGE2 | 8.8 | Amano et al. (2003) |
Compound 17 | Human | Erythroleukaemia cell/cAMP | Sulprostone | 6.89 | Gallant et al. (2002) |
Compound 18 | Human | rc-EP3/HEK-293E/binding | [3H]-PGE2 | 7.7 | Juteau et al. (2001) |
Compound 19 | Human | rc-EP3/HEK-293E/cAMP | PGE2 | 8.22 | Belley et al. (2005) |
EP4 receptor | |||||
AH-23848 | Sheep | Ductus arteriosus | PGE2 | ∼5.2a | Bouayad et al. (2001) |
Human | Middle cerebral artery | PGE2 | 5.7 | Davis et al. (2004) | |
Pig | Saphenous vein | PGE2 | 5.0 | Coleman et al. (1994a) | |
Rabbit | Saphenous vein | PGE2 | 4.96 | Lydford et al. (1996b) | |
Mouse | rc-EP4/CHO/cAMP | PGE2 | 5.3 | Nishigaki et al. (1995) | |
BGC-20-1531 | Human | rc-EP4/HEK-293E/cAMP | PGE2 | 7.6 | Maubach et al. (2009) |
Middle cerebral artery | PGE2 | 7.8 | Maubach et al. (2009) | ||
Dog | Middle meningeal artery | PGE2 | 7.7 | Maubach et al. (2009) | |
CJ-023423 | Human | rc-EP4/HEK-293/cAMP | PGE2 | 8.3 | Nakao et al. (2007) |
Rat | rc-EP4/HEK-293/cAMP | PGE2 | 8.2 | Nakao et al. (2007) | |
CJ-042794 | Human | rc-EP4/HEK-293/cAMP | PGE2 | 8.6 | Murase et al. (2008b) |
Rat | rc-EP4/HEK-293/cAMP | PGE2 | 8.7 | Murase et al. (2008a) | |
GW-627368 | Human | rc-EP4/HEK-293/cAMP | PGE2b | 7.9 | Wilson et al. (2006) |
Pulmonary vein | ONO-AE1-329 | 7.06 | Foudi et al. (2008) | ||
Pig | Saphenous vein | PGE2 | 9.2 | Wilson et al. (2006) | |
Rabbit | Saphenous vein | PGE2g | ≥8.5 | Jones and Chan. (2005) | |
L-161982 | Human | rc-EP4/HEK-293/cAMP | PGE2 | ∼8.5 | Machwate et al. (2001) |
BEAS-2B cell/CRE reporter | ONO-AE1-329 | 9.14 | L.M. Ayer and M.A. Giembycz (unpublished) | ||
Middle cerebral artery | PGE2 | 8.4 | Davis et al. (2004) | ||
Rat | rc-EP4/HEK-293/binding | [3H]-PGE2 | 7.50 | Machwate et al. (2001) | |
Periosteal cell/cAMP | PGE2 | 7.0c | Machwate et al. (2001) | ||
MF-498 | Human | rc-EP4/HEK-293/cAMP | PGE2 | 8.77c | Clark et al. (2008) |
ONO-AE2-227 | Mouse | rc-EP4/CHO/cAMP | PGE2 | 8.0c | Mutoh et al. (2002) |
ONO-AE3-208 | Mouse | rc-EP4/not given/binding | [3H]-PGE2 | 8.89 | Kabashima et al. (2002) |
Compound 20 | Human | rc-EP4/HEK-293E/cAMP | PGE2 | 8.49c | Burch et al. (2008) |
FP receptor | |||||
AS-604872 | Human | rc-FP/HEK-293E/PI | PGF2α | 7.33c | Cirillo et al. (2007) |
THG-113 | Pig | Retinal blood vessel | PGF2α | [6.34]c | Peri et al. (2006) |
THG-113.31 | Pig | Retinal blood vessel | PGF2α | [8.00]c | Peri et al. (2006) |
THG-113.824 | Pig | Retinal blood vessel | PGF2α | [8.96]c | Peri et al. (2006) |
THG-113.825 | Pig | Retinal blood vessel | PGF2α | 7.21c | Peri et al. (2006) |
Prostamide F receptor | |||||
AGN-204396 | Cat | Iris sphincter | Prostamide F2α | 5.64 | Woodward et al. (2007) |
IP receptor | |||||
RO-1138452 | Human | rc-IP/CHO/cAMP | Carbacyclin | 9.0 | Bley et al. (2006) |
Pulmonary artery | Cicaprost | 8.20 | Jones et al. (2006) | ||
Guinea pig | Aorta | Cicaprost | 8.39 | Jones et al. (2006) | |
Rabbit | Mesenteric artery | Cicaprost | 8.12 | Jones et al. (2006) | |
RO-3244794 | Human | rc-IP/CHO/cAMP | Carbacyclin | 8.5 | Bley et al. (2006) |
BEAS-2B cell/CRE reporter | Taprostene | 9.24 | L.A. Ayer and M.A. Giembycz (unpublished) | ||
Compound 21 | Rat | rc-IP/not given/cAMP | (Not given) | [8.12]h | Keitz et al. (2004) |
Compound 22 | Rat | UMR-106 osteosarcoma cell/cAMP | Iloprost | 6.41 | Nakae et al. (2005) |
Compound 23 | Rat | UMR-106 osteosarcoma cell/cAMP | Iloprost | 6.32 | Nakae et al. (2005) |
Compound 24 | Human | Platelet membrane/cAMP | Iloprost | 7.8c | Brescia et al. (2007) |
TP receptor | |||||
AA-2414 (Seratrodast) | Human | Bronchus | U-46619 | 7.7 | Itoh et al. (1993) |
Pig | Coronary artery | U-44069 | 9.0 | Imura et al. (1990) | |
Guinea pig | Aorta | U-46619 | 8.5 | Zhang et al. (1996) | |
Trachea | U-46619 | 7.69 | Ashida et al. (1989) | ||
Rat | Aorta | U-46619 | 7.8 | Zhang et al. (1996) | |
AH-23848 | Human | Bronchus | U-46619 | 8.5 | Coleman and Sheldrick (1989) |
Bronchus | U-46619 | 6.9 | McKenniff et al. (1988) | ||
Hand vein | U-46619 | 8.4 | Arner et al. (1991) | ||
Lung parenchyma | U-46619 | 8.7 | McKenniff et al. (1988) | ||
Platelet/aggregation | U-46619 | 8.05 | Tymkewycz et al. (1991) | ||
Guinea pig | Lung parenchyma | U-46619 | 8.7 | McKenniff et al. (1988) | |
Trachea | U-46619 | 8.7 | McKenniff et al. (1988) | ||
Trachea | U-46619 | 9.76 | Tymkewycz et al. (1991) | ||
Rat | Aorta | U-46619 | 8.47 | Tymkewycz et al. (1991) | |
Lung parenchyma | U-46619 | 6.9 | Norman et al. (1992) | ||
Platelet/aggregation | U-46619 | 8.19 | Tymkewycz et al. (1991) | ||
BAY-u3405 (Ramatroban) | Human | Bronchus | U-46619 | 8.8 | McKenniff et al. (1991) |
Pulmonary vein | U-46619 | 8.94 | Walch et al. (2001) | ||
Guinea pig | Lung parenchyma | U-46619 | 7.7 | Norman et al. (1992) | |
Trachea | U-46619 | 8.7 | McKenniff et al. (1991) | ||
Rat | Lung parenchyma | U-46619 | 8.6 | McKenniff et al. (1991) | |
BM-13177 (Sulotroban) | Human | Platelet/aggregation | U-46619 | 6.31 | Karasawa et al. (1991a) |
Guinea pig | Aorta | U-46619 | 5.58 | Karasawa et al. (1991b) | |
Rabbit | Jugular vein | U-46619 | 6.01 | Giles et al. (1989) | |
BM-13505 | Human | Hand vein | U-46619 | 7.9 | Arner et al. (1991) |
Platelet/aggregation | U-46619 | 7.75 | Karasawa et al. (1991a) | ||
Uterus (non-pregnant) | U-46619 | 7.4 | Senchyna and Crankshaw (1996) | ||
Guinea pig | Aorta | U-46619 | 6.89 | Dubéet al. (1992) | |
Aorta | U-46619 | 7.22 | Karasawa et al. (1991b) | ||
Aorta | U-46619 | 7.3 | Zhang et al. (1996) | ||
Lung parenchyma | U-46619 | 7.0 | Norman et al. (1992) | ||
Trachea | U-46619 | 7.73 | Dubéet al. (1992) | ||
Trachea | U-46619 | 7.5 | Ogletree and Allen (1992) | ||
Rat | Aorta | U-46619 | 8.2 | Zhang et al. (1996) | |
Aorta | U-46619 | 8.6 | Ogletree and Allen (1992) | ||
Lung parenchyma | U-46619 | 7.5 | Norman et al. (1992) | ||
BMS-180291 (Ifetroban) | Human | Platelet membrane/binding | [3H]-SQ-29548 | 8.4 | Ogletree et al. (1993) |
Guinea pig | Aorta | U-46619 | 9.8 | Zhang et al. (1996) | |
Rat | Aorta | U-46619 | 9.5 | Zhang et al. (1996) | |
CV-4151 | Human | Platelet/aggregation | U-46619 | 5.2 | Watts et al. (1991) |
Rabbit | Aorta | U-44069 | 5.9 | Imura et al. (1988) | |
EP-092 | Human | Bronchus | U-46619 | 7.37 | Featherstone et al. (1990) |
Bronchus | U-46619 | 6.8 | McKenniff et al. (1988) | ||
Lung parenchyma | U-46619 | 8.9 | McKenniff et al. (1988) | ||
Platelet /aggregation | U-46619 | 7.73 | Tymkewycz et al. (1991) | ||
Uterine artery | U-46619 | 8.5 | Baxter et al. (1995) | ||
Guinea pig | Lung parenchyma | U-46619 | 8.7 | McKenniff et al. (1988) | |
Trachea | U-46619 | 7.29 | Featherstone et al. (1990) | ||
Trachea | U-46619 | 8.7 | McKenniff et al. (1988) | ||
Trachea | U-46619 | 8.02 | Tymkewycz et al. (1991) | ||
Rat | Aorta | U-46619 | 8.55 | Tymkewycz et al. (1991) | |
Lung parenchyma | U-46619 | 7.1 | Norman et al. (1992) | ||
Platelet aggregation | U-46619 | 7.80 | Tymkewycz et al. (1991) | ||
EP-169 | Human | Platelet/aggregation | U-46619 | 8.30 | Tymkewycz et al. (1991) |
Pulmonary artery | U-46619 | ∼8.2 | Qian et al. (1994) | ||
Guinea pig | Trachea | U-46619 | 8.77 | Tymkewycz et al. (1991) | |
Rat | Aorta | U-46619 | 8.73 | Tymkewycz et al. (1991) | |
Platelet/aggregation | U-46619 | 8.48 | Tymkewycz et al. (1991) | ||
Glibenclamide | Human | Internal mammary artery | U-46619 | 6.3i | Stanke et al. (1998) |
Saphenous vein | 6.7i | Stanke et al. (1998) | |||
Dog | Coronary artery | U-46619 | 6.2 | Cocks et al. (1990) | |
Rabbit | Aorta | U-46619 | 6.08a | Pfister et al. (2004) | |
Guinea pig | Aorta | U-46619 | <5.0 | Kemp and McPherson (1998) | |
Rat | Aorta | U-46619 | 6.13 | Kemp and McPherson (1998) | |
GR-32191 (Vapiprost) | Human | Bladder (detrusor) | U-46619 | 8.27 | Palea et al. (1998) |
Bronchus | U-46619 | 8.77 | Featherstone et al. (1990) | ||
Bronchus | U-46619 | 8.40 | Armour et al. (1989) | ||
Platelet/binding | [3H]-GR-32191 | 8.66 | Armstrong et al. (1993) | ||
Pulmonary artery | U-46619 | 8.18 | Lumley et al. (1989) | ||
Saphenous vein | U-46619 | 8.93 | Furci et al. (1991) | ||
Umbilical artery | U-46619 | 8.0 | Boersma et al. (1999) | ||
Uterine artery | U-46619 | 8.5 | Baxter et al. (1995) | ||
Uterus (non-pregnant) | U-46619 | 8.6 | Senchyna and Crankshaw (1996) | ||
Uterus (pregnant) | U-46619 | 8.5a | Senior et al. (1993) | ||
Guinea pig | Aorta | U-46619 | 8.77 | Lumley et al. (1989) | |
Aorta | U-46619 | 9.4 | Ogletree and Allen (1992) | ||
Trachea | U-46619 | 8.26 | Featherstone et al. (1990) | ||
Trachea | U-46619 | 9.43 | Tymkewycz et al. (1991) | ||
Trachea | U-46619 | 10.0 | Ogletree and Allen (1992) | ||
Rat | Aorta | U-46619 | 7.87 | Lumley et al. (1989) | |
Aorta | U-46619 | 7.49 | Furci et al. (1991) | ||
Aorta | U-46619 | 8.41 | Tymkewycz et al. (1991) | ||
Aorta | U-46619 | 8.3 | Ogletree and Allen (1992) | ||
Trachea | U-46619 | 8.31 | Lydford and McKechnie (1994) | ||
GR-83783j | Rat | Aorta | U-46619 | 7.5 | Campbell et al. (1991a) |
GR-108774j | Rat | Aorta | U-46619 | 9.2 | Campbell et al. (1991b) |
ICI-192605 | Human | Platelet/aggregation | U-46619 | 8.16 | Brewster et al. (1988) |
Umbilical artery | U-46619 | 8.1 | Boersma et al. (1999) | ||
Umbilical vein | U-46619 | 9.07 | Daray et al. (2003) | ||
Uterus (non-pregnant) | U-46619 | 9.2 | Senchyna and Crankshaw (1996) | ||
Rat | Aorta | U-46619 | 8.4 | Brewster et al. (1988) | |
I-PTA-OH | Guinea pig | Lung parenchyma | U-46619 | 5.6 | Norman et al. (1992) |
Rat | Lung parenchyma | U-46619 | 5.8 | Norman et al. (1992) | |
I-SAP | Human | Platelet/aggregation | U-46619 | 8.01k | Naka et al. (1992) |
KW-3635 | Human | Platelet/aggregation | U-46619 | 8.88 | Karasawa et al. (1991a) |
Guinea pig | Aorta | U-46619 | 7.74 | Karasawa et al. (1991b) | |
L-655240 | Guinea pig | Aorta | U-44069 | 8.0 | Hall et al. (1987) |
Aorta | U-44069 | 8.0 | Hall et al. (1987) | ||
ONO-11120 | Human | Platelet/binding | [125I]-PTA-0H | 7.71c | Narumiya et al. (1986) |
Platelet/aggregation | U-46619 | 7.49 | Tymkewycz et al. (1991) | ||
Guinea pig | Trachea | U-46619 | 8.07 | Tymkewycz et al. (1991) | |
Rat | Aorta | U-46619 | 7.14 | Tymkewycz et al. (1991) | |
Platelet/aggregation | U-46619 | 7.38 | Tymkewycz et al. (1991) | ||
ONO-NT-126 | Human | Astrocytoma cell/PI | STA2 | 10.0 | Nakahata et al. (1990) |
Ridogrelj | Human | Platelet/aggregation | U-46619 | 5.7 | Watts et al. (1991) |
Rat | Tail artery | U-46619 | 5.5 | Janssens et al. (1990) | |
(±)-S-145 (Domitroban)l | Human | Astrocytoma cell/PI | STA2 | 8.48 | Nakahata et al. (1990) |
Platelet membrane/binding | [3H]-(+)-S-145 | 9.35 | Kishino et al. (1991) | ||
Rat | Aorta smooth muscle cell/binding | [3H]-SQ-29548 | 9.5a | Hanasaki et al. (1988) | |
S-18886 (Terutroban) | Rabbit | Saphenous vein | U-46619 | 8.9 | Cimetière et al. (1998) |
SQ-29548 | Human | Astrocytoma cell/PI | STA2 | 8.08 | Nakahata et al. (1990) |
Immortalized ciliary epithelial cell/PI | U-46619 | 7.7m | Sharif et al. (2002) | ||
Corpus cavernosum | U-46619 | 9.0 | Angulo et al. (2002) | ||
Umbilical artery | U-46619 | 7.6 | Boersma et al. (1999) | ||
Umbilical vein | U-46619 | 7.96 | Daray et al. (2003) | ||
Uterus (non-pregnant) | U-46619 | 8.2 | Senchyna and Crankshaw (1996) | ||
Pig | Coronary artery | U-46619 | 8.8a | Kromer and Tippins (1996) | |
Rabbit | Aorta | U-46619 | 7.95 | Yoshida et al. (2007) | |
Guinea pig | Aorta | U-46619 | 7.96 | Dubéet al. (1992) | |
Aorta | U-46619 | 8.9 | Ogletree and Allen (1992) | ||
Aorta | U-46619 | 8.5 | Zhang et al. (1996) | ||
Lung parenchyma | U-46619 | 7.7 | Norman et al. (1992) | ||
Trachea | U-46619 | 8.70 | Dubéet al. (1992) | ||
Trachea | U-46619 | 8.9 | Ogletree and Allen (1992) | ||
Rat | Aorta | U-46619 | 9.2 | Zhang et al. (1996) | |
Lung parenchyma | U-46619 | 7.2 | Norman et al. (1992) | ||
SQ-30741 | Human | Coronary artery | U-46619 | 7.54 | Maassen VanDenBrink et al., 1996) |
Human | Umbilical artery | U-46619 | 7.0 | Boersma et al. (1999) | |
Guinea pig | Aorta | U-46619 | 8.1 | Ogletree and Allen (1992) | |
Trachea | U-46619 | 8.6 | Ogletree and Allen (1992) | ||
Rat | Aorta | U-46619 | 7.9 | Ogletree and Allen (1992) | |
YM-158 | Guinea pig | Trachea | U-46619 | 8.81n | Arakida et al. (1998) |
Z-335 | Human | Platelet membrane/binding | [3H]-SQ-29548 | 7.52 | Tanaka et al. (1998) |
Platelet/shape changeo | U-46619 | 8.02 | Yoshida et al. (2007) | ||
Rabbit | Aorta | U-46619 | 8.64 | Yoshida et al. (2007) | |
ZD-1542j | Guinea pig | Lung parenchyma | U-46619 | 8.5 | Brownlie et al. (1993) |
Trachea | U-46619 | 8.3 | Brownlie et al. (1993) | ||
Rat | Aorta | U-46619 | 8.51 | Brownlie et al. (1993) |
pA2 values relate to functional assays. Recombinant (rc-) systems: prostanoid receptor followed by the carrier cell line and second messenger measurement. Smooth muscle preparations: contraction or relaxation of induced tone. Platelets: all data from plasma-free platelet suspensions. Where pA2 values are not available, pKi/pKD values derived from radioligand binding are given (italics). Affinity values in square brackets derive from the patent literature.
Structures of compounds: 1–5, Figure 1; 6–12, Figure 2; 13–15, Figure 3; 16–19, Figure 4; 20, Figure 5; 21–24, Figure 7.
BEAS, human bronchial epithelium; CHO, Chinese hamster ovary; COS-7, African green monkey kidney; HEK, human embryonic kidney; CRE, cAMP response element; 16,16-DM PGE2, 16,16-dimethyl PGE2; PI, phosphoinositide.
Our calculation.
Appreciable affinity for corresponding TP receptor.
pIC50.
Insurmountable antagonism in functional DP2 systems.
1 µM SC-51322 present.
Replacement for sulprostone, which had slow onset and offset.
Possible interference by EP2 system.
pKi.
pKb for non-competitive antagonism.
Combined TP antagonist/TXS inhibitor.
Shape change seen.
Data for (+)- and (−)-enantiomers in Kishino et al. (1991).
Non-competitive antagonism.
pA2= 8.87 for LTD4 antagonism.
Suppression of maximum aggregation response.